Marsha E Samson1, Nancy G Porter1, Deborah M Hurley1, Swann A Adams1, Jan M Eberth1. 1. From the Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, Columbia, and the Department of Health & Environmental Control, South Carolina Central Cancer Registry, Columbia.
Abstract
OBJECTIVES: Breast cancer is the most frequently diagnosed cancer among women and the second-leading cause of female cancer deaths in the United States. African Americans and other minorities in the United States experience lower survival rates and have a worse prognosis than European Americans despite European Americans having a much higher incidence of the disease. Adherence to breast cancer treatment-quality measures is limited, particularly when the data are stratified by race/ethnicity. METHODS: We aimed to examine breast cancer incidence and mortality trends in South Carolina by race and explore possible racial disparities in the quality of breast cancer treatment received in South Carolina. RESULTS: African Americans have high rates of mammography and clinical breast examination screenings yet suffer lower survival compared with European Americans. For most treatment-quality metrics, South Carolina fairs well in comparison to the United States as a whole; however, South Carolina hospitals overall lag behind South Carolina Commission on Cancer-accredited hospitals for all measured quality indicators, including needle biopsy utilization, breast-conserving surgeries, and timely use of radiation therapy. Accreditation may a play a major role in increasing the standard of care related to breast cancer diagnosis and treatment. CONCLUSIONS: These descriptive findings may provide significant insight for future interventions and policies aimed at eliminating racial/ethnic disparities in health outcomes. Further risk-reduction approaches are necessary to reduce minority group mortality rates, especially among African American women.
OBJECTIVES:Breast cancer is the most frequently diagnosed cancer among women and the second-leading cause of female cancer deaths in the United States. African Americans and other minorities in the United States experience lower survival rates and have a worse prognosis than European Americans despite European Americans having a much higher incidence of the disease. Adherence to breast cancer treatment-quality measures is limited, particularly when the data are stratified by race/ethnicity. METHODS: We aimed to examine breast cancer incidence and mortality trends in South Carolina by race and explore possible racial disparities in the quality of breast cancer treatment received in South Carolina. RESULTS: African Americans have high rates of mammography and clinical breast examination screenings yet suffer lower survival compared with European Americans. For most treatment-quality metrics, South Carolina fairs well in comparison to the United States as a whole; however, South Carolina hospitals overall lag behind South Carolina Commission on Cancer-accredited hospitals for all measured quality indicators, including needle biopsy utilization, breast-conserving surgeries, and timely use of radiation therapy. Accreditation may a play a major role in increasing the standard of care related to breast cancer diagnosis and treatment. CONCLUSIONS: These descriptive findings may provide significant insight for future interventions and policies aimed at eliminating racial/ethnic disparities in health outcomes. Further risk-reduction approaches are necessary to reduce minority group mortality rates, especially among African American women.
Authors: Rowan T Chlebowski; Zhao Chen; Garnet L Anderson; Thomas Rohan; Aaron Aragaki; Dorothy Lane; Nancy C Dolan; Electra D Paskett; Anne McTiernan; F Alan Hubbell; Lucile L Adams-Campbell; Ross Prentice Journal: J Natl Cancer Inst Date: 2005-03-16 Impact factor: 13.506
Authors: Swann Arp Adams; James R Hebert; Susan Bolick-Aldrich; Virginie G Daguise; Catishia M Mosley; Mary V Modayil; Sondra H Berger; Jane Teas; Michael Mitas; Joan E Cunningham; Susan E Steck; James Burch; William M Butler; Marie-Josephe D Horner; Heather M Brandt Journal: J S C Med Assoc Date: 2006-08
Authors: Craig C Earle; Mary Beth Landrum; Jeffrey M Souza; Bridget A Neville; Jane C Weeks; John Z Ayanian Journal: J Clin Oncol Date: 2008-08-10 Impact factor: 44.544
Authors: Swann A Adams; Emily R Smith; James Hardin; Irene Prabhu-Das; Jeanette Fulton; James R Hebert Journal: Cancer Date: 2009-12-15 Impact factor: 6.860
Authors: Marsha E Samson; Swann A Adams; Anwar T Merchant; Whitney D Maxwell; Jiajia Zhang; Charles L Bennett; James R Hebert Journal: Arch Gynecol Obstet Date: 2016-07-11 Impact factor: 2.344
Authors: Marsha E Samson; Swann Arp Adams; Caroline M Mulatya; Jiajia Zhang; Charles L Bennett; James Hebert; Susan E Steck Journal: Maturitas Date: 2016-10-22 Impact factor: 4.342
Authors: Muhammad Umar Jawad; Brad H Pollock; Barton L Wise; Lauren N Zeitlinger; Edmond F O' Donnell; Janai R Carr-Ascher; Amy Cizik; Betty Ferrell; Steven W Thorpe; R Lor Randall Journal: J Surg Oncol Date: 2021-12-10 Impact factor: 2.885
Authors: Jie Ding; Alison T Stopeck; Yi Gao; Marilyn T Marron; Betsy C Wertheim; Maria I Altbach; Jean-Philippe Galons; Denise J Roe; Fang Wang; Gertraud Maskarinec; Cynthia A Thomson; Patricia A Thompson; Chuan Huang Journal: J Magn Reson Imaging Date: 2018-04-06 Impact factor: 4.813
Authors: Oluwole Adeyemi Babatunde; Jan M Eberth; Tisha Felder; Robert Moran; Samantha Truman; James R Hebert; Jiajia Zhang; Swann Arp Adams Journal: J Racial Ethn Health Disparities Date: 2020-05-08
Authors: R Costas-Muniz; J Amir; M Paris; D Spratt; J Arevalo-Perez; S Fareedy; C J González; F Gany; M Camacho-Rivera; J R Osborne Journal: J Community Med Health Educ Date: 2017-02-20
Authors: Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Carolyn Cotton; Karam F A Soliman Journal: Mol Med Rep Date: 2020-06-15 Impact factor: 2.952